Objective: To determine the prevalence of obesity according to the AACE/ACE framework based on a complications-centric model with further application of the Cardiometabolic Disease Staging (CMDS) system in Venezuelan population. 
Introduction
Excess body fat increases the likelihood of diabetes, hypertension, coronary heart disease, stroke, certain cancers, obstructive sleep apnea, and osteoarthritis. 1, 2 Overweight and obesity, represented by increased body mass index (BMI) 25-29.9 kg/m 2 and ≥30 kg/m 2 , respectively, were the sixth leading global disease burden, accounting for 3.4 million deaths per year and 3.8% of global disability-adjusted life years (DALY; sum of years lived with disability and years of life lost) in 2013. 3 In Latin America (LA), BMI values have increased 1.1 kg/m 2 in men and 0.7 kg/m 2 in women, per decade, from 1980 to 2008; 4 placing an increased BMI as the third regional cause of disease burden. 3 A national population survey to investigate the prevalence of overweight and obesity has not been performed in Venezuela. 5 Based on published regional and sub-national studies (7) in 3,368 subjects, 6 the weighted prevalenceaccording to the size sample of each study included-of obesity (BMI ≥30 kg/m 2 ) in Venezuela was calculated at 26.3%.
The new perspective of obesity as a chronic, complex disease 7 imposes a new clinical and epidemiological approach to patients with unhealthy accumulation, distribution, and function of fat mass. The current definition of obesity is based on the BMI. 8 However, accumulation of excess body fat represents a continuum that includes overweight individuals with a lesser degree of excessive adiposity that can also adversely impact health as well as metabolically healthy individuals with obesity. 9 The phenotypic and metabolic spectrum of obesity is influenced by race, ethnicity, and body type, 9 demanding a refinement of BMI cut-offs to diagnose obesity in different populations, and the need for additional measures of adiposity, such as waist circumference (WC) or body fat percentage. 10 A complete cardiometabolic health diagnosis does not only depend upon BMI value. The BMI as isolated both diagnosis and clinical decision-making tool can underperforms, whereas a complications centric approach will provide a better understanding of impact of increased body fat on health. 7 In addressing this issue, the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE), 11 in 2014, asserted that BMI per se does not reflect the impact of weight gain on the health or wellbeing of the individual. Consequently, AACE/ACE proposed a medical definition of obesity incorporating not only the continued use of BMI, but also other physical assessments including the presence and severity of obesity-related complications (ORC) to reflect the health impact of adiposity for individual patients (AACE/ACE framework). 11, 12 Of note, the prevalence rates for obesity and ORC according to this AACE/ACE framework are unknown.
The objective of this study was to determine the prevalence of obesity and ORC according to the AACE/ACE framework in five populations in the Venezuelan Metabolic Syndrome, Obesity and Lifestyle Study (VEMSOLS), as well as assessing risks for each obesity stage using the Cardiometabolic Disease Staging (CMDS) system.
Furthermore, these results were compared with data using other definitions, including the World Health Organization (WHO) BMI cut-off points, 13 fat mass percentage, 10 and abdominal obesity with cut-offs adapted to Latin America.
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Material and methods
Population studied
The study was designed to evaluate five populations in three regions from Venezuela:
Palavecino Municipality (urban) 
Clinical and biochemical data
All subjects were evaluated in their home or in a nearby health center by a trained health care team according to a standardized protocol. Each home was visited twice. In the first visit, the participants received information about the study and the written informed consent was obtained. Demographic and clinical information was obtained using a standardized questionnaire. Blood pressure (BP) was measured twice in the right arm supported to the heart level, in sitting position, after five minutes of rest, using a calibrated aneroid sphygmomanometer. Weight was measured with the fewest clothes possible, without shoes, using a calibrated scale. Height was measured using a metric tape on the wall. BMI was calculated as weight (kg)/height (m) 2 . Body fat percent (BF %) by leg bioimpedance (Tanita®, Tanita Corp., Tokyo, Japan) was obtained from 529 participants. Waist circumference (WC) was measured at the iliac crest, in a plane horizontal to the floor at the end of expiration.
In the second visit, blood samples were drawn after 12 hours of overnight fasting. The samples were centrifuged for 15 minutes at 3000 rpm within 30-40 minutes after collection, transported on dry ice to the central laboratory, and properly stored (-40°C) until analysis. Glucose plasma concentration, 15 
Categorization of variables
Obesity prevalence was estimated using five different definitions and staging systems.
First, obesity and overweight were defined according to the AACE/ACE framework 11, 12 and 
Results
Subjects characteristics
Approximately two thirds of the sample was female. Both genders had similar age and BMI. Men had higher weight, height, and WC than women, but lower BF% ( Table 2) .
Prevalence of obesity according to AACE/ACE framework
The prevalence of obesity (stages 0-2) according to the AACE/ACE framework was 63.5% ( 
Prevalence of obesity by other definitions
According to the WHO classification of obesity, two thirds of subjects had overweight or obesity (Table 4 -A). Half of the subjects had excess adiposity by BF% and abdominal obesity by increased waist circumference, although these rates were somewhat higher in men than women (Table 4 -B, C). The prevalence of obesity and overweight, according to the WHO, varied with age, being more prevalent in the middle-aged groups (p < 0.05) ( Table 5) . Mean values of all cardiometabolic risk factors were increased as a function of the WHO-BMI classification, with the exception of blood glucose, which was not influenced by BMI category (Table 3B) . Lipid values, except HDL-c and total cholesterol, were similar between subjects with overweight and obesity.
The prevalence rates of obesity according to all definitions are provided in Figure 2 and demonstrate how the new AACE/ACE framework improves the detection of subjects at risk when compared with other definitions.
Discussion
The new AACE/ACE diagnostic framework for obesity allows integrative evaluation of patients using both anthropometric measures to confirm excess adiposity and clinical measures involving the detection and staging of ORCs, which increases the identification of subjects at risk in a general population study of Venezuela. The Therefore, with this projection and current screening and diagnostic strategies, it will be unlikely that the goal proposed to halt the rise of non-communicable diseases for 2025 can be reached. 23 The WHO had estimated that by 2014, more than half billion of subjects with obesity, and the prevalence calculated in the Region of the Americas (27%) was similar to the results in the present study (29.3%).
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These discouraging figures result from the exclusive use of BMI to detect obesity -a BMI-centric model -which impairs public health strategies and emerging personalized care by underestimating the number of people with excess body fat (not to mention whether the abnormal adiposity is biologically relevant 26 Similar BMI cutoffs were found in 750 subjects in a general population sample from three of the regions included in the present study.
Therefore, it should be noted that in Venezuela and other populations, many people without obesity would be re-classified as subjects with obesity based on direct measurements of body adiposity. Likewise, 22.7% more individuals were detected with central obesity using waist circumference cutoffs specific for LA, compared with using BMI alone. These findings in tandem reinforce the recommendation to complement the BMI-centric obesity with other anthropometrics to better delineate individual cardiometabolic risk. 10 The new, advanced AACE/ACE framework to define obesity as a chronic, complex disease based on a complications-centric system for those with BMI ≥ 25 kg/m optimizes the public health model even further by incorporating biological relevance. 11, 12 Thus, stepwise application of the AACE/ACE framework 11, 12 Several limitations of this study deserve mention. First, the AACE/ACE framework included many of the specified weight-related complications that were not formally screened or evaluated. However, this would only have had an effect of amplifying our findings that a BMI-centric protocol underestimated the clinical relevance and adverse impact of excess weight. Second, this study was retrospective in nature, and prospective observational studies would add further confirmation of these findings. A specific strength of this study is the application of a U.S. developed obesity framework to a Latin American country with a distinctly different ethno-cultural makeup. This type of instrument can not only detect previously unrecognized but salient attributes of a local obesity problem, but can offer pathways for public health initiatives based on ORC nature and severity.
Conclusion
The new perspective of obesity as a chronic complex disease demands an integrated and structured approach to early detection of subjects at high risk. The AACE/ACE framework to diagnose obesity identifies greater numbers of subjects with ORC at lower levels of fat mass in Venezuela, translating to a higher preponderance of cardiometabolic risk, socio-economic burden, and public health challenges. Thus, structured programs and policies must be expeditiously formulated, transculturalized, and implemented to seize control over a massive obesity problem by preventing and managing ORC. rk.
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